3 The Medicinal Chemistry of the P2 Receptor Family

Progress in Medicinal Chemistry

Volumn 38, Issue C, 2001, Pages 115-187

  Guile, Simon D ^a   Ince, Francis ^a   Ingall, Anthony H ^a   Kindon, Nicholas D ^a   Meghani, Premji ^a   Mortimore, Michael P ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 N (2 METHYLTHIOETHYL) 2 (3,3,3 TRIFLUOROPROPYLTHIO)ADENOSINE PHOSPHATE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CLOPIDOGREL; DRUG DERIVATIVE; EYE DROPS; INS 365; PURINE P2 RECEPTOR; TICLOPIDINE;

ANIMAL; ARTERIOSCLEROSIS; CHEMISTRY; CYSTIC FIBROSIS; HUMAN; METABOLISM; MOLECULAR CLONING; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION;

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMAL; ARTERIOSCLEROSIS; CLONING, MOLECULAR; CYSTIC FIBROSIS; HUMAN; OPHTHALMIC SOLUTIONS; RECEPTORS, PURINERGIC P2; STRUCTURE-ACTIVITY RELATIONSHIP; TICLOPIDINE; TISSUE DISTRIBUTION;

EID: 0035233851     PISSN: 00796468     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6468(08)70093-6     Document Type: Article

References (266)

1. Burnstock G. In: Straub R.W., and Bolis L. (Eds). Cell Membrane Receptors for Drugs and Hormones: Multidisciplinary Approach (1978), Raven, New York 107-118
2. Burnstock G., and Kennedy C. Gen. Pharmacol. 16 (1985) 433-440
3. Fredholm B.B., Burnstock G., Harden T.K., and Spedding M. Drug Dev. Res. 39 (1996) 461-466
4. Hall D.A., and Hourani S.M.O. Br. J. Pharmacol. 108 (1993) 728-733
5. Lewis C.J., Neidhart S., Holy C., North R.A., Buell G.N., and Surprenant A. Nature (London)) 377 (1995) 432-435
6. Le K.T., Babinski K., and Seguela P. J. Neurosci. 18 (1998) 7152-7159
7. Torres G.E.E., Haines W.R., Egan T.M., and Voigt M.M. Mol. Pharmacol. 54 (1998) 989-993
8. King B.F., Townsend-Nicholson A., and Burnstock G. Trends Pharmacol. Sci. 19 (1998) 506-514
9. Abbracchio M.P., and Burnstock G. Pharmacol. Ther. 64 (1994) 445-475
10. Lazarowski E.R., Homolya L., Boucher R.C., and Harden T.K. J. Biol. Chem. 272 (1997) 20402-20407
11. Vigne P., Breittmayer J.P., and Frelin C. Br. J. Pharmacol. 125 (1998) 675-680
12. Westfall T.D., Mclntyre C.A., Obeid S., Bowes J., Kennedy C., and Sneddon P. Br. J. Pharmacol. 121 (1997) 57-62
13. Lewis C.J., Surprenant A., and Evans R.J. Br. J. Pharmacol. 124 (1998) 1463-1466
14. Kennedy C., and Leff P. Trends Pharmacol. Sci. 16 (1995) 168-174
15. Dainty I.A., Dougall I.G., Mckay G.D., and Leff P. Br. J. Pharmacol. 20 (1997) 299P
16. Filtz T.M., Li Q., Boyer L.J., Nicholas R.A., and Harden T.K. Mol. Pharmacol. 46 (1994) 8-14
17. Ralevic V., and Burnstock G. Pharmacol. Rev. 50 (1998) 413-492
18. Collo G., North R.A., Kawashima E.E., Merlo-Pich E., Neidhart S., Surprenant A., and Buell G.N. J. Neurosci. 16 (1996) 2495-2507
19. Rassendren F., Buell G.N., Virginio C., Collo G., North R.A., and Surprenant A. J. Biol. Chem. 272 (1997) 5482-5486
20. Brake A.J., Wagenbach M.J., and Julius D. Nature (London)) 371 (1994) 519-523
21. Torres G.E.E., Egan T.M., and Voigt M.M. J. Biol. Chem. 274 (1999) 6653-6659
22. Bean B.P. Trends Pharmacol. Sci. 13 (1992) 87-90
23. Dubyak G.R., and El-Moatassim C. Am. J. Physiol. 265 (1993) C577-C606
24. Valera S., Hussy N., Evans R.J., Adami N., North R.A., Surprenant A., and Buell G.N. Nature (London)) 371 (1994) 516-519
25. Valera S., Talabot F., Evans R.J., Gos A., Antonarakis S.E., Morris M.A., and Buell G.N. Recept. Channels 3 (1995) 283-289
26. Savi P., Bornia J., Salel V., Delfaud M., and Herbert J.M. Br. J. Haematol. 98 (1997) 880-886
27. MacKenzie A.B., Mahaut-Smith M.P., and Sage S.O. J. Biol. Chem. 271 (1996) 2879-2881
28. Somasundaram B., and Mahaut-Smith M.P. J. Physiol. 480 (1994) 225-231
29. Bianchi B.R., Lynch K.J., Touma E., Niforatos W., Burgard E.C., Alexander K.M., Park H.S., Yu H., Metzger R., Kowaluk E., Jarvis M.F., and van Biesen T. Eur. J. Pharmacol. 37 6 (1999) 127-138
30. Dunn P.M., and Blakeley A.G. Br. J. Pharmacol. 93 (1988) 243-245
31. Voogd T.E., Vansterkenburg E.L., Wilting J., and Janssen L.H. Pharmacol. Rev. 45 (1993) 177-203
32. Nakazawa K., Inoue K., Ito K., and Koizumi S. Naunyn-Schmiedeberg's Arch. Pharmacol. 351 (1995) 202-208
33. Bultmann R., Wittenburg H., Pause B., Kurz G., Nickel P., and Starke K. Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 498-504
34. Darner S., Niebel B., Cseche S., Nickel P., Ardanuy U., Schmalzing G., Rettinger J., Mutschler E., and Lambrecht G. Eur. J. Pharmacol. 350 (1998) R5-R6
35. Rettinger J., Schmalzing G., Damer S., Muller G., Nickel P., and Lambrecht G. Arch. Pharmacol. 359 (1999) 31
36. Lambrecht G., Friebe T., Grimm U., Windscheif U., Bungardt E., Hildebrandt C., Baumert H.G., Spatz-Kumbel G., and Mutschler E. Eur. J. Pharmacol. 217 (1992) 217-219
37. Buell G.N., Lewis C.J., Collo G., North R.A., and Surprenant A. EMBO J. 15 (1996) 55-62
38. Kim Y.C. Drug Dev. Res. 45 (1998) 52-66
39. Evans R.J., Lewis C., Buell G., Valera S., North R.A., and Surprenant A. Mol. Pharmacol. 48 (1995) 178-183
40. Bultmann R., and Starke K. Naunyn-Schmiedeberg's Arch. Pharmacol. 348 (1993) 684-687
41. Wittenburg H., Bultmann R., Pause B., Ganter C., Kurz G., and Starke K. Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 491-497
42. Bultmann R., Trendelenburg M., Tuluc F., Wittenburg H., and Starke K. Naunyn-Schmiedeberg's Arch. Pharmacol. 359 (1999) 339-344
43. Tuluc F., Bultmann R., Glanzel M., Frahm A.W., and Starke K. Naunyn-Schmiedeberg's Arch. Pharmacol. 35 7 (1998) 111-120
44. Choo L.K. J. Pharm. Pharmacol. 33 (1981) 248-250
45. Bultmann R., Driessen B., Goncalves J., and Starke K. Naunyn-Schmiedeberg's Arch. Pharmacol. 351 (1995) 555-560
46. Virginio C., Robertson G., Surprenant A., and North R.A. Mol. Pharmacol. 53 (1998) 969-973
47. Surprenant A. Naunyn-Schmiedeberg's Arch. Pharmacol. 358 (1998) SC32-SC32
48. Garcia-Guzman M., Stuhmer W., and Soto F.L. Brain Res. Mol. Brain Res. 47 (1997) 59-66
49. Souslova V., Ravenall S., Fox M., Wells D., Wood J.N., and Akopian A.N. Gene 195 (1997) 101-111
50. Chen C.C., Akopian A.N., Sivilotti L., Colquhoun D., Burnstock G.K., and Wood J.N. Nature (London) 377 (1995) 428-431
51. Virginio C., Robertson G., Surprenant A., and North R.A. Mol. Pharmacol. 53 (1998) 969-973
52. Bo X., Zhang Y., Nassar M., Burnstock G.K., and Schoepfer R. FEBS Lett. 375 (1995) 129-133
53. Seguela P., Haghighi A., Soghomonian J.J., and Cooper E. J. Neurosci. 16 (1996) 448-455
54. Garcia-Guzman M., Soto F.L., Gomez-Hernandez J.M., Lund P.E., and Stuhmer W. Mol. Pharmacol. 51 (1997) 109-118
55. Wang C.Z., Namba N., Gonoi T., Inagaki N., and Seino S. Biochem. Biophys. Res. Commun. 220 (1996) 196-202
56. Michel A.D., Miller K.J., Lundstrom K., Buell G.N., and Humphrey P.P.A. Mol. Pharmacol. 51 (1997) 524-532
57. Garcia-Guzman M., Soto F., Laube B., and Stuhmer W. FEBS Lett. 388 (1996) 123-127
58. Tokuyama, Y., Mereu, L., Chen, X., Rouard, M., and Bell, G. I. (1999) Direct submission of U49395 to GenBank.
59. Tokuyama, Y., Mereu, L., Chen, X., Rouard, M., and Bell, G. I. (1999) Direct submission of U49396 to GenBank.
60. Groschel-Stewart U.B., Bardini M., Robson T., and Burnstock G. Cell Tissue Res. 297 (1999) 111-117
61. Chan C.M., Unwin R.J., and Burnstock G. J. Amer. Soc. Nephrol. 9 (1998) 420A Program and Abstr. Issue
62. Groschel-Stewart U.B., Bardini M., Robson T., and Burnstock G. Cell Tissue Res. 296 (1999) 599-605
63. Soto F., Garcia-Guzman M., Karschin C., and Stuhmer W. Biochem. Biophys. Res. Commun. 223 (1996) 456-460
64. Surprenant A., Rassendren F., Kawashima E., North R.A., and Buell G. Science (Washington, D. C.) 272 (1996) 735-738
65. Chessell L.P., Simon J., Hibell A.D., Michel A.D., Barnard E.A., and Humphrey P.P.A. FEBS Lett. 439 (1998) 26-30
66. Chessell L.P., Simon J., Hibell A.D., Michel A.D., and Humphrey P.P.A. Drug Dev. Res. 43 (1998) 3
67. Virginio C., MacKenzie A., North R.A., and Surprenant A. Soc. Neurosci. Abstr. 23 (1997) 376
68. Virginio C., MacKenzie A., North R.A., and Surprenant A. J. Physiol. (Cambridge) 519 (1999) 335-346
69. Schulze-Lohoff E., Gruber A., Rost S., Schoecklmann H., Messmer U., Brune B., and Sterzel R.B. Drug Dev. Res. 37 (1996) 176
70. Collo G., Neidhart S., Kawashima E., Kosco-Vilbois M., North R.A., and Buell G. Neuropharmacology 36 (1997) 1277-1283
71. Hargreaves A.C., and Pollard C.E. J. Physiol. (Cambridge) (1998) 131P-132P
72. Brandle U., Kohler K., and Wheeler-Schilling T.H. Brain Res., Mol. Brain Res. 62 (1998) 106-109
73. Cockcroft S., and Gomperts B.D. Biochem. J. 188 (1980) 789-798
74. Tatham P.E.R., Cusack N.J., and Gomperts B.D. Eur. J. Pharmacol. 80 (1988) 13-21
75. Bowers K.C., Lawson M., and Christie M.I. Drug Dev. Res. 37 (1996) 126
76. Buell G., Chessell L.P., Michel A.D., Collo G., Salazzo M., Herren S., Gretener D., Grahames C., Kaur R., Kosco-Vilbois M.H., and Humphrey P.P.A. Blood 92 (1998) 3521-3528
77. Virginio C., Church D., North R.A., and Surprenant A. Neuropharmacology 36 (1997) 1285-1294
78. Murgia M., Hanau S., Pizzo P., Rippa M., and Di Virgilio F. J. Biol. Chem. 268 (1993) 8199-8203
79. Wiley J.S., Chen R., and Jamieson G.P. Arch. Biochem. Biophys. 305 (1993) 54-60
80. Wiley J.S., Chen R., Wiley M.J., and Jamieson G.P. Arch. Biochem. Biophys. 292 (1993) 411-418
81. Chessell L.P., Michel A.D., and Humphrey P.P.A. Br. J. Pharmacol. 124 (1998) 1314-1320
82. Soltoff S.P., McMillian M.K., Talamo B.R., and Cantley L.C. Biochem. Pharmacol. 45 (1993) 1936-1940
83. Blanchard D.K., Hoffman S.L., and Djeu J.Y. J. Cell. Biochem. 57 (1995) 452-464
84. Humphreys B.D., and Dubyak G.R. J. Immunol. 157 (1996) 5627-5637
85. Gargett C.E., and Wiley J.S. Br. J. Pharmacol. 120 (1997) 1483-1490
86. Humphreys B.D., Virginio C., Surprenant A., Rice J., and Dubyak G.R. Mol. Pharmacol. 54 (1998) 22-32
87. Baxter, A., Cheshire, D., Mclnally, T., Mortimore, M. and Cladingboel, D. (1999) PCT Int. Appl. WO 99 29686.
88. Chem. Abstr. 131 (1999) 44809
89. Baxter, A., Brough, S., Mclnally, T., Mortimore, M. and Cladingboel, D. (1999) PCT Int. Appl. WO 99 29660.
90. Chem. Abstr. 131 (1999) 44659
91. Baxter, A., Mclnally, T., Mortimore, M. and Cladingboel, D. (1999) PCT Int. Appl. WO 99 29661.
92. Chem. Abstr. 131 (1999) 58652
93. Le K.T., Boue-Grabot E., Archambault V., and Seguela P. J. Biol. Chem. 4 (1999) 15415-15419 27
94. Webb T.E., Simon J., Krishek B.J., Bateson A.N., Smart T.G., King B.F., Burnstock G., and Barnard E.A. FEBS Lett. 324 (1993) 219-225
95. Simon J., Webb T.E., King B.F., Burnstock G., and Barnard E.A. Eur. J. Pharmacol. 291 (1995) 281-289
96. Pacaud P., Feolde E., Frelin C., and Loirand G. Br. J. Pharmacol. 118 (1996) 2213-2219
97. Tokuyama Y., Hara M., Jones E.M.C., Fan Z., and Bell G.I. Biochem. Biophys. Res. Commun. 211 (1995) 211-218
98. Henderson D.J., Elliot D.G., Smith G.M., Webb T.E., and Dainty I.A. Biochem. Biophys. Res. Commun. 212 (1995) 648-656
99. Ayyanathan K., Webbs T.E., Sandhu A.K., Athwal R.S., Barnard E.A., and Kunapuli S.P. Biochem. Biophys. Res. Commun. 218 (1996) 783-788
100. Leon C., Vial C., Cazenave J.P., and Gachet C. Gene 171 (1996) 295-297
101. Schachter J.B., Li Q., Boyer J.L., Nicholas R.A., and Harden T.K. Br. J. Pharmacol. 118 (1996) 167-173
102. Janssens R., Communi D., Pirotton S., Samson M., Parmentier M., and Boeynaems J.M. Biochem. Biophys. Res. Commun. 221 (1996) 588-593
103. Boyer J.L., Lazarowski E.R., Chen X.H., and Harden T.K. J. Pharmacol. Exp. Ther. 267 (1993) 1140-1146
104. Webb T.E., Feolde E., Vigne P., Neary J.T., Runberg A., Frelin C., and Barnard E.A. Br. J. Pharmacol. 119 (1996) 1385-1392
105. Boyer J.L., Zohn I.E., Jacobson K.A., and Harden T.K. Br. J. Pharmacol. 113 (1994) 614-620
106. Boyer J.L., Romero-Avila T., Schachter J.B., and Harden T.K. Mol. Pharmacol. 50 (1996) 1323-1329
107. Schachter J.B., Boyer J.L., Li Q., Nicholas R.A., and Harden T.K. Br. J. Pharmacol. 122 (1997) 1021-1024
108. Leon C., Hechler B., Vial C., Leray C., Cazenave J.P., and Gachet C. FEBS Lett. 403 (1997) 26-30
109. Fagura M.S., Dainty I.A., Mckay G.D., Kirk L.P., Humphries R.G., Robertson M.J., Dougall I.G., and Leff P. Br. J. Pharmacol. 124 (1998) 157-164
110. Fischer B., Boyer J.L., Hoyle C.H.V., Ziganshin A.U., Brizzolara A.L., Knight G.E., Zimmet J., Burnstock G., Harden T.K., and Jacobson K.A. J. Med. Chem. 36 (1993) 3937-3946
111. Burnstock G., Fischer B., Hoyle C.H.V., Maillard M., Ziganshin A.U., Brizzolara A.L., von Isakovics A., Boyer J.L., Harden K., and Jacobson K.A. Drug Dev. Res. 31 (1994) 206-219
112. Palmer R.K., Boyer J.L., Schachter J.B., Nicholas R.A., and Harden T.K. Mol. Pharmacol. 54 (1998) 1118-1123
113. Boyer J.L., Siddiqi S., Fischer B., Romero-Avila T., Jacobson K.A., and Harden T.K. Br. J. Pharmacol. 118 (1996) 1959-1964
114. Jacobson K.A., Kim Y.C., Camaioni E., and Van Rhee A.M. In: Turner J.T., Weisman G.A., and Fedan J.S. (Eds). The Receptors Series; The P2 Nucleotide Receptors (1998), Humana Press Inc, Totowa, New Jersey, USA 81-107
115. Camaioni E., Boyer J.L., Mohanram A., Harden T.K., and Jacobson K.A. J. Med. Chem. 41 (1998) 183-190
116. Nandanan E., Camaioni E., Jang S.Y., Kim Y.C., Cristalli G., Herdewijn P., Secrist J.A., Tiwari K.N., Mohanram A., Harden T.K., Boyer J.L., and Jacobson K.A. J. Med. Chem. 42 (1999) 1625-1638
117. Boyer J.L., Mohanram A., Camaioni E., Jacobson K.A., and Harden T.K. Br. J. Pharmacol. 124 (1998) 1-3
118. Van Rhee A.M., Fischer B., Van Galen P.J.M., and Jacobson K.A. Drug Des. Discovery 13 (1995) 133-154
119. Jiang Q., Guo D., Lee B.X., Van Rhee A.M., Kim Y.C., Nicholas R.A., Schachter J.B., Harden T.K., and Jacobson K.A. Mol. Pharmacol. 52 (1997) 499-507
120. Moro S., Guo D., Camaioni E., Boyer J.L., Harden T.K., and Jacobson K.A. J. Med. Chem. 41 (1998) 1456-1466
121. Moro S., Hoffmann C., and Jacobson K.A. Biochemistry 38 (1999) 3498-3507
122. Hoffmann C., Moro S., Nicholas R.A., Harden T.K., and Jacobson K.A. J. Biol. Chem. 274 (1999) 14639-14647
123. Williams M., and Jacobson K.A. Expert Opin. Invest. Drugs 4 (1995) 925-934
124. Abbracchio M.P., and Burnstock G. Jpn. J. Pharmacol. 78 (1998) 113-145
125. Boarder M.R., and Hourani S.M.O. Trends Pharmacol. Sci. 19 (1998) 99-107
126. Brown, F., Mitchell, D. E., Rahim, A. T. and Stewart, B. R. (1998) PCT Int. Appl. WO 98 03178.
127. Chem. Abstr. 128 (1998) 139449
128. Pelleg, A. and Schulman, E. B. (1998) PCT Int. Appl. WO 98 42353.
129. Chem. Abstr. 129 (1998) 285987
130. Rapaport, E. (1996) U.S. 5547942.
131. Chem. Abstr. 125 (1996) 158638
132. Lustig K.D., Shiau A.K., Brake A.J., and Julius D. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 5113-5117
133. Goedecke S., Decking U.K.M., Goedecke A., and Schrader J. Am. J. Physiol. 270 (1996) C570-C577
134. Rice W.R., Burton F.M., and Fiedeldey D.T. Am. J. Respir. Cell Mol. Biol. 12 (1995) 27-32
135. Chen Z.P., Krull N., Xu S., Levy A., and Lightman S.L. Endocrinology 137 (1996) 1833-1840
136. Seye, C. I., Gadeau, A. P., and Desgranges, C. (1996) Direct submission of U56839 to GenBank.
137. Parr C.E., Sullivan D.M., Paradiso A.M., Lazarowski E.R., Burch L.H., Olsen J.C., Erb L., Weisman G.A., Boucher R.C., and Turner J.T. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3275-3279
138. Bowler W.B., Birch M.A., Gallagher J.A., and Bilbe G. J. Bone Miner. Res. 10 (1995) 1137-1145
139. Boarder M.R. In: Turner J.T., Weisman G.A., and Fedan J.S. (Eds). The Receptors Series; The P2 Nucleotide Receptors (1998), Humana Press Inc, Totowa, New Jersey, U.S.A. 185-209
140. Dasari V.R., Sandhu A.K., Mills D.C.B., Athwal R.S., and Kunapuli S.P. Somatic Cell Mol. Genet. 22 (1996) 75-79
141. Janssens R. Br. J. Pharmacol. 127 (1999) 709-716
142. O'Connor S.E. Life Sci. 50 (1992) 1657-1664
143. Fitz J.G., and Sostman A.H. Am. J. Physiol. 266 (1994) G544-G553
144. Munshi R., DeBernardi M.A., and Brooker G. Mol. Pharmacol. 44 (1993) 1185-1191
145. Post S.R., Jacobson J.P., and Insel P.A. J. Biol. Chem. 271 (1999) 2029-2032
146. Clarke L.L., Harline M.C., Otero M.A., Glover G.G., Garrad R.C., Krugh B., Walker N.M., Gonzalez F.A., Turner J.T., and Weisman G.A. Am. J. Physiol. 276 (1999) C777-C787
147. Garrad R.C., Otero M.A., Gonzalez F.A., Turner J.T., Clarke L.L., and Weisman G.A. Drug Dev. Res. 43 (1998) 12
148. Garrad R.C., Otero M.A., Erb L., Theiss P.M., Clarke L.L., Gonzalez F.A., Turner J.T., and Weisman G.A. J. Biol. Chem. 273 (1998) 29437-29444
149. Ralevic V., and Burnstock G. Circulation 84 (1991) 1-14
150. Ralevic V., and Burnstock G. Circ. Res. 69 (1991) 1583-1590
151. Ralevic V., and Burnstock G. Br. J. Pharmacol. 118 (1996) 428-434
152. Ralevic V., and Burnstock G. Br. J. Pharmacol. 117 (1996) 1797-1802
153. Kuroki M., Takeshige K., and Minakami S. Biochim. Biophys. Acta 1012 (1989) 103-106
154. Seifert R., and Schultz G. Biochem. J. 259 (1989) 813-819
155. Seifert R., Wenzel K., Ekstein F., and Schultz G. Eur. J. Biochem. 181 (1989) 277-285
156. Walker B.A., Hagenlocker B.E., Douglas V.K., Tarapchak S.J., and Ward P.A. Lab. Invest. 64 (1991) 105-112
157. Verghese M.W., Kneisler T.B., and Boucheron J.A. J. Biol. Chem. 271 (1996) 15597-15601
158. Mason S.J., Paradiso A.M., and Boucher R.C. Br. J. Pharmacol. 103 (1999) 1649-1656
159. Clark L.L., and Boucher R.C. Am. J. Physiol. 263 (1992) C348-C356
160. Stutts M.J., Chinet T.C., Mason S.J., Fulton J.M., Clarke L.L., and Boucher R.C. Proc. Natl. Acad. Sci. U.S.A. 89 (1999) 1621-1625
161. Wolkoff L.L., Perrone R.D., Grubman S.A., Lee D.W., Soltoff S.P., Rogers L.C., Beinborn M., Fang S.L., and Cheng S.H. Cell Calcium 17 (1995) 375-383
162. Martin S.C., and Shuttleworth T.J. Br. J. Pharmacol. 115 (1995) 321-329
163. Drutz D.J., Shaffer C., and LaCroix K. Drug Dev. Res. 37 (1996) 185
164. Yerxa B.R., and Johnson F.L. Drugs Future 24 (1999) 759-769
165. Lethem M., Dowell M., and Scott M.V. Am. J. Respir. Cell Mol. Biol. 9 (1993) 315-322
166. Dixon C.J., Bowler W.B., Littlewood-Evans A., Dillon J.P., Bilbe G., Sharpe G.R., and Gallagher J.A. Br. J. Pharmacol. 127 (1999) 1680-1686
167. Saig B., Bodin P., Shacoori V., Catheline M., Rault B., and Burnstock G. Endothelium 2 (1995) 279-285
168. Enomoto K., Furaya K., Yamagishi S., Oka T., and Maeno T. Arch. Eur. J. Physiol. 427 (1994) 533-542
169. Lazarowski E.R., Homolya L., Boucher R.C., and Harden T.K. J. Biol. Chem. 272 (1997) 24348-24354
170. Goetz V., Prada M.D., and Pletscher A. J. Pharmacol. Exp. Ther. 178 (1971) 210-215
171. Lazarowski E.R. Br. J. Pharmacol. 127 (1999) 1272-1278
172. Nicholas R.A., Watt W.C., Lazarowski E.R., Li Q., and Harden T.K. Mol. Pharmacol. 50 (1996) 224-229
173. Lazarowski E.R., Watt W.C., Stutts M.J., Boucher R.C., and Harden T.K. Br. J. Pharmacol. 116 (1995) 1619-1627
174. Pendergast W., Siddiqi S.M., Ridout J.L., and Dougherty M.K. Drug Dev. Res. 37 (1999) 133
175. Lazarowski E.R., Watt W.C., Stutts M.J., Brown H.A., Boucher R.C., and Harden T.K. Br. J. Pharmacol. 117 (1996) 203-209
176. Pintor J., and Miras-Portugal M.T. Drug Dev. Res. 28 (1993) 259-262
177. Pendergast, W., Yerxa, B. R., Rideout, J. L. and Siddiqi, S. M. (1998) PCT Int. Appl. WO 98 34942.
178. Chem. Abstr. 129 (1998) 175919
179. Drutz, D. J., Rideout, J. L. and Jacobus, K. M. (1997) PCT Int. Appl. W097 29756.
180. Chem. Abstr. 127 (1997) 215207
181. Yerxa, B. R., Jacobus, K. M., Pendergast, W. and Rideout, J. L. (1998) PCT Int. Appl. WO 98 34593.
182. Chem. Abstr. 129 (1998) 180137
183. Knoblauch B.H.A., Sauer R., Jarlebark L., Luwoko G., Heilbronn E., and Mueller C.E. Drug Dev. Res. 43 (1998) 34
184. Shaver S.R., Pendergast W., Siddiqi S.M., Yerxa B.R., Croom D.K., Dougherty R.W., James M.K., Jones A.N., and Rideout J.L. Nucleosides Nucleotides 16 (1997) 1099-1102
185. Charlton S.J., Brown C.A., Weisman G.A., Turner J.T., Erb L., and Boarder M.R. Br. J. Pharmacol. 119 (1996) 1301-1303
186. Kindon, N., Meghani, P. and Thom, S. (1998) PCT Int. Appl. WO 98 45309.
187. Chem. Abstr. 129 (1998) 302810
188. Kindon, N., Meghani, P. and Thorn, S. (1999) PCT Int. Appl. WO 9902501.
189. Chem. Abstr. 130 (1999) 139357
190. Kindon, N., Meghani, P. and Thom, S. (1999) PCT Int. Appl. WO 9905123.
191. Chem. Abstr. 130 (1999) 153665
192. Kindon, N., Meghani, P. and Thom, S. (1999) PCT Int. Appl. WO 9926944.
193. Chem. Abstr. 131 (1999) 19017
194. Kindon, N., Meghani, P. and Thom, S. (1998) PCT Int. Appl. WO 9854180.
195. Chem. Abstr. 130 (1998) 38394
196. Anon. Expert Opin. Ther. Pat. 9 (1999) 205-207
197. Boarder M.R., Weisman G.A., Turner J.T., and Wilkinson G.F. Trends Pharmacol. Sci. 16 (1995) 133-138
198. Erb L., Garrad R., Wang Y., Quinn T., Turner J.T., and Weisman G.A. J. Biol. Chem. 270 (1995) 4185-4188
199. Bennett W.D., Oliver K.N., Zeman K.L., Hohneker K.W., Boucher R.C., and Knowles M.R. Am. J. Respir. Crit. Care Med. 15 3 (1996) 1796-1801
200. Bennett W.D., Oliver K.N., Zeman K.L., Hohneker K.W., Boucher R.C., Knowles M.R., and Edwards L.J. Am. J. Respir. Crit. Care Med. 154 (1996) 217-223
201. Shaffer C., Jacobus K., and Yerxa B. Pediatr. Pulmonol. 17 (1998) 254
202. Anon. (1999) PJB Pharmaprojects CD ROM v 2.1.
203. Webb T.E., Henderson D., King B.F., Wang S., Simon J., Bateson A.N., Burnstock G., and Barnard E.A. Mol. Pharmacol. 50 (1996) 258-265
204. Li Q., Olesky M., Palmer R.K., Harden T.K., and Nicholas R.A. Mol. Pharmacol. 54 (1998) 541-546
205. Communi D., Pirotton S., Parmentier M., and Boeynaems J.M. J. Biol. Chem. 270 (1995) 30849-30852
206. Nguyen T., Erb L., Weisman G.A., Marchese A., Heng H.H.Q., Garrad R.C., George S.R., Turner J.T., and O'Dowd B.F. J. Biol. Chem. 270 (1995) 30845-30848
207. Bogdanov Y.D., Wildman S.S., Clements M.P., King B.F., and Burnstock G. Br. J. Pharmacol. 124 (1998) 428-430
208. Stam N.J., Klomp J., van de Heuvel M., and Olijve W. FEBS Lett. 384 (1996) 260-264
209. Maier R., Glatz A., Mosbacher J., and Bilbe G. Biochem. Biophys. Res. Commun. 237 (1997) 297-302
210. Jin J., Dasari V.R., Sistare F.D., and Kunapuli S.P. Br. J. Pharmacol. 123 (1998) 789-794
211. Bogdanov Y., Rubino A., and Burnstock G. Life Sci. 62 (1998) 697-703
212. Merten M.D., Saleh A., Kammouni W., Marchand S., and Figarella C. Eur. J. Biochem. 251 (1998) 19-24
213. Communi D., Bernard R., Janssens R., and Parmentier M. Drug Dev. Res. 45 (1998) 130-134
214. Communi D., Motte S., Boeynaems J.M., and Pirotton S. Eur. J. Pharmacol. 317 (1996) 383-389
215. Robaye B., Boeynaems J.M., and Communi D. Eur. J. Pharmacol. 329 (1997) 231-236
216. Communi D., Paindavoine P., Place G.A., Parmentier M., and Boenynaems M. Br. J. Pharmacol. 127 (1999) 562-568
217. Engelhardt J.F., Yankansas J.R., Ernst S.A., Yang Y., Marino C.R., Boucher R.C., Colin J.A., and Wilson J.M. Nat. Genet. 2 (1992) 240-248
218. Webb T.E., Kaplan M.G., and Barnard E.A. Biochem. Biophys. Res. Commun. 219 (1996) 105-110
219. Li Q., Schachter J.B., Harden T.K., and Nicholas R.A. Biochem. Biophys. Res. Commun. 236 (1997) 455-460
220. Chang K., Hanaoka K., Kumada M., and Takuwa Y. J. Biol. Chem. 270 (1995) 26152-26158
221. Communi D., Parmentier M., and Boeynaems J.M. Biochem. Biophys. Res. Commun. 222 (1996) 303-308
222. Lazarowski E.R., Paradiso A.M., Watt W.C., Harden T.K., and Boucher R.C. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2599-2603
223. Inoue C.N., Woo J.S., Schwiebert E.M., Morita T., Hanaoka K., Guggino S.E., and Guggino W.B. Am. J. Physiol. 272 (1997) C1862-C1870
224. Boucher, R. C., Jr., Shaver, S. R., Pendergast, W., Yerxa, B., Rideout, J. L., Dougherty, R. and Croom, D. (1999) PCT Int. Appl. WO 99 09998.
225. Chem. Abstr. 130 (1999) 218304
226. Akbar G.K.M., Dasari V.R., Webb T.E., Ayyanathan K., Pillarisetti K., Sandhu A.K., Athwal R.S., Daniel J.L., and Ashby B. J. Biol. Chem. 271 (1996) 18363-18367
227. Herold C.L., Li Q., Schachter J.B., Harden T.K., and Nicholas R.A. Biochem. Biophys. Res. Commun. 235 (1997) 717-721
228. Yokomizo T., Izumi T., Chang K., Takuwa Y., and Shimizu T. Nature (London) 387 (1997) 620-624
229. Bogdanov Y.D., Dale L., King B.F., Whittock N., and Burnstock G. J. Biol. Chem. 272 (1997) 12583-12590
230. Communi D., Govaerts C., Parmentier M., and Boeynaems J.M. J. Biol. Chem. 272 (1997) 31969-31973
231. Puri R.N., and Colman R.W. J. Protein Chem. 17 (1998) 429-451
232. Cusack N.J., and Hourani S.M. Br. J. Pharmacol. 73 (1981) 405-408
233. Cusack N.J., and Hourani S.M. Br. J. Pharmacol. 73 (1981) 409-412
234. Cusack N.J., and Hourani S.M. Br. J. Pharmacol. 75 (1982) 257-259
235. Cusack N.J., and Hourani S.M. Br. J. Pharmacol. 75 (1982) 397-400
236. Cusack N.J., and Hourani S.M. Br. J. Pharmacol. 76 (1982) 221-227
237. Daniel J.L., Dangelmaier C., Jin J., Ashby B., Smith J.B., and Kunapuli S.P. J. Biol. Chem. 273 (1998) 2024-2029
238. Jin J., and Kunapuli S.P. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 8070-8074
239. Gachet C., Cazenave J.P., Ohlmann P., Hilf G., Wieland T., and Jakobs K.H. Eur. J. Biochem. 207 (1992) 259-263
240. Colman R.W. Proc. Soc. Exp. Biol. Med. 197 (1991) 242-248
241. Hourani S.M., and Hall D.A. Ciba Found. Symp. 198 (1996) 53-64
242. Geiger J., Honig-Liedl P., Schanzenbacher P., and Walter U. Eur. J. Pharmacol. 351 (1998) 235-246
243. Gough G., Maguire M.H., and Penglis F. Mol. Pharmacol. 8 (1972) 170-177
244. Puri R.N., Colman R.F., and Colman R.W. Arch. Biochem. Biophys. 343 (1997) 140-145
245. Hourani S.M.O. Drug Dev. Res. 38 (1996) 12-23
246. Ingall A.H., Dixon J., Bailey A., Coombs M.E., Cox D., Mclnally J.I., Hunt S.F., Kindon N.D., Teobald B.J., Willis P.A., Humphries R.G., Leff P., Clegg J.A., Smith J.A., and Tomlinson W. J. Med. Chem. 42 (1999) 213-220
247. Humphries R.G., Tomlinson W., Ingall A.H., Cage P.A., and Leff P. Br. J. Pharmacol. 113 (1994) 1057-1063
248. Ingall, A. H., Bailey, A., Coombs, M. E., Hunt, S. F., Ince, F., Teobald, B. J., Willis, P. A., Leff, P., Humphries, R. G., Nicol, A. K., and Tomlinson, W. (1998) Abstracts of XVth EFMC International Symposium on Medicinal Chemistry, Edinburgh, U.K., September 1998, Poster No. 280.
249. Brown, R., Pairaudeau, G., Springthorpe, B., Thorn, S. and Willis, P. (1999) PCT Int. Appl. WO 994 1254.
250. Chem. Abstr. 131 (1999) 184960
251. Hardern, D. and Springthorpe, B. (1999) PCT Int. Appl. WO 99 05142.
252. Chem. Abstr. 130 (1999) 153657
253. Brown, R. and Pairaudeau, G. (1999) PCT Int. Appl. WO 99 05144.
254. Chem. Abstr. 130 (1999) 153658
255. Guile, S., Ingall, A., Springthorpe, B. and Willis, P. (1999) PCT Int. Appl. WO 9905143.
256. Chem. Abstr. 130 (1999) 168386
257. Bonnert, R., Ingall, A., Springthorpe, B. and Willis, P. (1998) PCT Int. Appl. WO 98 28300.
258. Chem. Abstr. 129 (1998) 95506
259. Asai, F., Sugidachi, A., Ikeda, T., Koike, H., Inoue, T., Takata, K., Iwamura, R., Kita, J. and Yoneda, K. (1998) PCT Int. Appl. EP 934928 equivalent to WO 98 08811.
260. Chem. Abstr. 128 (1998) 217289
261. Savi, P., Pereillo, J. M. A., Fedeli, O., Reversat, J. L., Maftouh, M., Uzabiaga, M. F., Rouchon, M. C., Combalbert, J., Picard, C., Maffrand, J. P., Pascal, M. and Herbert, J. M. (1999) Abstracts of the International Society of Thrombosis and Haemostasis XVIIth Congress, Washington D. C., U.S.A. 14-21 August 1999.
262. Asai, F., Sugidachi, A., Ogawa, T., Nagasawa, T., Shimoji, T., Suzuki, N., Kawamura, Y., Inoue, T. and Iwamura, R. (1999) Abstracts of the International Society of Thrombosis and Haemostasis XVIIth Congress, Washington D. C., U.S.A. 14-21 August 1999.
263. Anon. Med. Sci. Bull. (Internet Enhanced J. Pharmacol. Ther.) 20 (1997) 243. http://pharminfo.com/pubs/msb/clopid243.html http://pharminfo.com/pubs/msb/clopid243.html
264. Nandanan E., Camaioni E., Jang S.Y., Kim Y.C., Cristalli G., Herdewijn P., Secrist J.A., Tiwari K.N., Mohanram A., Harden T.K., Boyer J.L., and Jacobson K.A. J. Med. Chem. 42 (1999) 1625-1638
265. Cusack N.J. Drug Dev. Res. 28 (1993) 244-252
266. Humphries R.G., Tomlinson W., Clegg J.A., Ingall A.H., Kindon N.D., and Leff P. Br. J. Pharmacol. 115 (1995) 1110-1116